These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7065335

  • 21. Current issues in the pioneer versus generic drug wars.
    Safir PO.
    Food Drug Law J; 1995; 50(2):335-9. PubMed ID: 10343002
    [No Abstract] [Full Text] [Related]

  • 22. Lawsuits anticipated on generic biologicals front.
    Fox JL.
    Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
    [No Abstract] [Full Text] [Related]

  • 23. Strategies That Delay Market Entry of Generic Drugs.
    Vokinger KN, Kesselheim AS, Avorn J, Sarpatwari A.
    JAMA Intern Med; 2017 Nov 01; 177(11):1665-1669. PubMed ID: 28975217
    [Abstract] [Full Text] [Related]

  • 24. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
    Bongiorno RA, Nutescu EA.
    Semin Thromb Hemost; 2004 Dec 01; 30(6):619-26. PubMed ID: 15630667
    [Abstract] [Full Text] [Related]

  • 25. FDA: keynote address, PDA/FDA conference.
    Chesemore RG.
    J Parenter Sci Technol; 1991 Dec 01; 45(2):71-5. PubMed ID: 1675676
    [Abstract] [Full Text] [Related]

  • 26. [Generic drugs and the rights of substitution].
    Vallée JP.
    Presse Med; 1999 Mar 13; 28(10):535-8. PubMed ID: 10209545
    [Abstract] [Full Text] [Related]

  • 27. Generic vs. brand name drugs--defining and enforcing standards.
    Lasagna LC.
    Internist; 1979 May 13; 20(4):11, 13. PubMed ID: 10316827
    [No Abstract] [Full Text] [Related]

  • 28. Hatch-Waxman Turns 30: Do We Need a Re-Designed Approach for the Modern Era?
    Kesselheim AS, Darrow JJ.
    Yale J Health Policy Law Ethics; 2015 May 13; 15(2):293-347. PubMed ID: 26333236
    [Abstract] [Full Text] [Related]

  • 29. American Pharmaceutical Association House of Delegates, May 13-18 1978, Montreal, Quebec, Canada. Report of the Policy Committe on Public Affairs.
    Am Pharm; 1978 Jul 15; 18(8 Spec No):22-9. PubMed ID: 665504
    [No Abstract] [Full Text] [Related]

  • 30. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV, Kirkegaard H, Kruse E, Kruse PR.
    Theriaca; 2016 Jul 15; (43):9-61. PubMed ID: 27491172
    [Abstract] [Full Text] [Related]

  • 31. MAC--a cutting tool for federal reimbursements on prescription drugs?
    Hirsh HL.
    J Leg Med (N Y); 1976 Feb 15; 4(2):31-3. PubMed ID: 1082483
    [No Abstract] [Full Text] [Related]

  • 32. Physician-ownership in pharmacies and drug repackagers.
    Hoffer GE.
    Inquiry; 1975 Mar 15; 12(1):26-36. PubMed ID: 123219
    [No Abstract] [Full Text] [Related]

  • 33. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle.
    Felch WC.
    Internist; 1979 May 15; 20(4):3-5. PubMed ID: 10242131
    [No Abstract] [Full Text] [Related]

  • 34. The "Long" amendment.
    Provost GP.
    Am J Hosp Pharm; 1967 Dec 15; 24(12):665. PubMed ID: 6073365
    [No Abstract] [Full Text] [Related]

  • 35. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY, Jiang W, Lionberger R, Wong J, Jones JW, Kane MA, Krumholz A, Temple R, Polli JE.
    Epilepsia; 2015 Sep 15; 56(9):1415-24. PubMed ID: 26201987
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.